Disease ⇒ Anxiety {40000113}
Type: | Disease |
---|---|
Definition: | Anxiety |
Parent: | [ ] |
Initialisation date: | 2020-09-06 |
---|---|
Other Terms: | Generalized Anxiety Disorder |
MedDra ID: | [ ] |
---|---|
MedDra Level: | [ ] |
ICD: | [ ] |
Category: | Psychiatry |
Zone: | [ ] |
Mechanism: | [ ] |
Notes:
- Bifidobacterium longum increase of BDNF levels and normalization of behavior. (1)
- Bifidobacterium infantis exaggerated HPA stress response (1)
Shared Notes
- [1.1]
- Stress and anxiety are related to gut dysbiosis.
- Ingesting Lactobacillus plantarum P-8 (P-8) improved stress/anxiety symptoms.
- Symptoms were relieved by modulating gut microbiota and neuroactive potential. - [1.5]
- Combination of probiotics and polyphenol-rich prebiotics, a synbiotic >attenuates the chronic-stress induced inflammatory responses in the ileum and the prefrontal cortex promoting > resilience to the consequent depressive- and anxiety-like behaviors in male mice.
- This effect may be attributed to specific synbiotic-produced metabolites including 4-hydroxyphenylpropionic, 4-hydroxyphenylacetic acid and caffeic acid > promoted anti-inflammatory activity through the aryl hydrocarbon receptor (AHR). - [1.2]
- Lactobacillus reuteri and Bifidobacterium adolescentis Probitica > reduction in depressive symptoms at four and eight weeks of treatment, and anxiety symptoms at four weeks.
> improvement in sleep quality.
- Lactobacillus reuteri and Bifidobacterium adolescentis Probitica > decrease in serum interleukin-6 levels.
- Lactobacillus reuteri and Bifidobacterium adolescentis Probitica > increased Bifidobacteriaceae and Lactobacillacea, whereas it decreased Enterobacteriaceae in the gut microbiota composition. - [1.3]
- mice exposed to 4EPS displayed anxiety-like behaviours, and pharmacological treatments that promote oligodendrocyte differentiation prevented the behavioural effects of 4EPS.